Vaccines and stimulative policy have made DM’s leaders of global recovery. But we are cautious as record equity issuance and inflows create a tug-of-war.
March was an exciting month if you were investing or following U.S. Treasuries. Yields continued their seemingly relentless climb on the back of unremitting good news on vaccines, economic data and a repricing of Fed policy.
In 2019, we published our Morgan Stanley Investment Management (MSIM) Fixed Income “ESG and Sovereign Fixed Income Investing: A Better Way” approach. We highlighted our thesis that countries’ sustainability performance should be evaluated in the context of their stage of development.
Jim Caron, Portfolio Manager and Head of Global Macro Strategies for the Global Fixed Income Team, shares his macro thematic views on key market drivers.
A mass-market brand aims to sell to all the buyers of the category. In fact, the typical buyer of a brand is a light buyer. Take a certain globally known soft drinks manufacturer:
Cyclical recovery continues: Global equities continued their move up for most of February and after a volatile final week, they closed the month positive at 2.4% (MSCI ACWI in USD terms1), despite markets’ nervousness over the prospect of inflation and rate rises.
Laura Bottega discusses how global factors encourage companies to balance profit and ESG.
How to record ESG company risks and opportunities in a consistent and comparable way? The International Equity Team explains the Material Risk Indicator.
